Skip to main content
Figure 2 | Reproductive Biology and Endocrinology

Figure 2

From: Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction

Figure 2

Patient disposition. Patients were considered to have had an under-response if there was failure to develop at least one follicle of 10–12 mm in diameter after 35 days of r-hFSH stimulation. Patients were considered to have had an over-response if they developed more than three follicles of >14 mm in diameter and/or their E2 levels were >900 pg/mL after 35 days of r-hFSH stimulation. AFC = antral follicle count; BMI = body mass index; CLD = chronic low-dose; E2 = oestradiol; hCG = human chorionic gonadotrophin; LD = low-dose; PP = per-protocol; PRL = prolactin; r-hFSH = recombinant human follicle-stimulating hormone.

Back to article page